← Leaderboards
Emily Flynn
Stanford University
$91,796
Attributed
$91,796
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $37.8K · FY2019–21$50K$37.5K$25K$12.5K$0
'19
'20
'21
Funding mix
By agency
NIH$91,796 · 1
By mechanism
F31$91,796 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Berenice Anath Benayoun$5,625,117
- Holden T. Maecker$29,621,634
- Joseph C Wu$80,370,369
- Marlene Rabinovitch$40,032,014
- Ruth M O'Hara$58,199,787
Others in their field
Other Emerging Leaders on “Adverse Drug Event”
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,144,108
- Caroline Sigman · Ccs Associates, Inc.$13,846,650
- Andrew S Huhn · Johns Hopkins University$12,205,195
- Mary E Hamby · Cognition Therapeutics, Inc.$9,832,688
- Elizabeth Fox · St. Jude Children'S Research Hospital$8,840,232
Research focus
Adverse Drug EventAdverse EventAdverse Event RiskAwarenessBaseBayesian MethodBindingBiologicalBiological ProcessBiological SexBiologyBrainCareerCaringCell LineClinically RelevantCollaborationsComputer AnalysisConsensusData AggregationData AnalysesData SetDrug DevelopmentAdipose Tissue
Grant awards (3)
Toward improved understanding of sex differences in drug response: developing gene and pathway-based informatics methods to examine sex-differential genetic effects$17,117
F31 · FY2021 · LM · contact PI
Toward improved understanding of sex differences in drug response: developing gene and pathway-based informatics methods to examine sex-differential genetic effects$37,750
F31 · FY2020 · LM · contact PI
Toward improved understanding of sex differences in drug response: developing gene and pathway-based informatics methods to examine sex-differential genetic effects$36,929
F31 · FY2019 · LM · contact PI